Therefore, this study aims to investigate the correlation between CHI3L1 and liver fibrosis in AILDs, compare serum CHI3L1 with other liver fibrosis assessment methods to explore its clinical application value as a non-invasive diagnostic biomarker for liver fibrosis. This evidence concerns the gene CHI3L1 and Hepatic fibrosis.